SEPTIC ARTHRITIS AND BACTEREMIA DUE TO MYCOPLASMA RESISTANT TO ANTIMICROBIAL THERAPY IN A PATIENT WITH SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:20
作者
CLOUGH, W
CASSELL, GH
DUFFY, LB
RINALDI, RZ
BLUESTONE, R
MORGAN, MA
MEYER, RD
机构
[1] CEDARS SINAI MED CTR,DEPT MED,CLIN MICROBIOL LAB,DIV INFECT DIS,8700 BEVERLY BLVD,BECKER BLDG,LOS ANGELES,CA 90048
[2] CEDARS SINAI MED CTR,DEPT PATHOL,LOS ANGELES,CA 90048
[3] CEDARS SINAI MED CTR,DEPT MED,CLIN MICROBIOL LAB,DIV RHEUMATOL,LOS ANGELES,CA 90048
[4] UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294
[5] UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,LOS ANGELES,CA 90024
关键词
D O I
10.1093/clind/15.3.402
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We report a case of septic arthritis caused by Mycoplasma hominis in a patient with systemic lupus erythematosus. The infection started as monarthritis but spread to at least four joints despite apparently suitable therapy with various antimicrobial agents, including doxycycline, clindamycin, and ciprofloxacin; subsequent bacteremia was documented. Control was ultimately achieved with use of the experimental fluoroquinolone temafloxacin in combination with doxycycline administration, arthroscopic drainage of a persistently infected joint, several intravenous infusions of immunoglobulins (which led to increases in levels of antibodies specific to M. hominis), and discontinuation of corticosteroid therapy. Antimicrobial susceptibility testing of various mycoplasmal isolates showed the presence of the tetM gene, disparity between susceptibility to tetracycline and doxycycline, and increasing resistance to most antimicrobial agents used (including to fluoroquinolones before clinical use), although the patient ultimately had a favorable clinical response to treatment with combined modalities.
引用
收藏
页码:402 / 407
页数:6
相关论文
共 33 条